Here are the 10 most expensive states for long‑term care in 2025 — a crucial read for retirement planning and senior care budgeting: www.thinkadvisor.com/2026/03/06/10-most-expen...
#LongTermCare #RetirementCosts #HealthcareEconomics
If nothing else, it’s a helpful reminder that payment reform experiments are happening everywhere… and many of the lessons are remarkably consistent across borders.
buff.ly/N8EE70V
#HealthPolicy #ValueBasedCare #GlobalHealth #PaymentReform #HealthcareEconomics
Portrait of Professor Tobias Klein
Today at #HCHE: Prof. Tobias Klein (Tilburg University) explores if GP incentives can cut costs vs patient copays. “Is Physician Cost-Sharing an Alternative to Patient Cost-Sharing?” 📅 Jan 26, 2026 🕓 16:00–17:15 📍 Hamburg (HCHE) #HealthcareEconomics #GPIncentives #HealthPolicy #HealthcareCosts
not because it tells you what to do, but because it’s a rare, honest framing of the terrain we’re all operating in.
Highly recommend the read. buff.ly/J28eIB4
#HealthcareEconomics #ValueBasedCare #HealthPolicy #HealthcareFinance #ActuarialScience
US President says agreements with more drugmakers will lower costs for patients; critics question what savings consumers will actually see.
longevity.technology/news/trump-s...
#longevity #drugpricing #healthpolicy #pharmaindustry #healthcareeconomics #publichealth
McLean County's Treasurer reveals promising tax receipts and investment returns, but alarming financial strains at the nursing home raise serious concerns.
Click to read more!
#McLeanCounty #IL #PublicFinance #McLeanCountyFinance #CitizenPortal #TaxRevenueTrends #HealthCareEconomics
www.nursewhowrites.com/post/refutin...
#NursingShortageMyth #NurseStaffing #HealthcareEconomics #MedicalErrors #HospitalUnderstaffing #PatientSafety #NurseAdvocacy #HealthcareReform #NurseWhoWrites #ShiftWorkersParadox #SystemicChange #NursingLeadership #WorkforceReality #ClinicalEthics
Medical innovation drives progress — but it comes at a high cost.
Understand the balance between science, risk, and the pursuit of better patient outcomes in this episode:
👉 youtu.be/SLS2C6uPxSA
#HealthcareEconomics #DrugDiscovery #SkyHealthAcademy
A cost-effectiveness analysis of initial BRV versus LEV therapy was conducted across the US, Australia, and Japan.
doi.org/10.1002/epi4...
#epilepsy #ILAE #epilepsiaopen #antiseizuremedication #healthcareeconomics #levetiracetam #riskstratification
#hospitals #hospitaladministration #healthcare #healthcareeconomics #americanhealthcare #affordablehealthcare
jamanetwork.com/journals/jam...
Transforming Primary Care with PAs (Physician Assistants)
🚑 Transforming Primary Care with PAs (Physician Assistants)
Team-based care is reshaping healthcare delivery — and PAs are at the center of it.
Read here: backlinkmonk.com/primary-care...
#PrimaryCare #HealthcareInnovation #PhysicianAssistants #TeamBasedCare #HealthcareEconomics #BacklinkMonk
8/9 The government justifies charges by citing waste: $135 million worth of doses discarded in 2023-24.
But experts argue free vaccines reduce ER visits, hospital admissions, and long COVID cases - saving money overall.
#HealthcareEconomics
A core theme: Do financial incentives, especially from private equity, stifle dental innovation? Skepticism exists that new tech not boosting dentist margins might be suppressed, hindering adoption of potentially beneficial tools. #HealthcareEconomics 2/6
医療にもコスパかぁ!スマホみたいに納得して選びたいもんね!僕の研究もISPORで認められたなんて嬉しいな!みんなもブログ見てみてね! #医療経済 #費用対効果 #HealthcareEconomics
LifeNextDaily News!
Excited to share that Healthcare Economist has been ranked #4 in health policy blogs! See how it's making waves! #HealthPolicy #HealthcareEconomics #TopBlog
Click here↓↓↓
LifeNextDaily News!
🚀⚡️💰 Wondering how healthcare subscriptions are changing the game? Discover who's winning and who's losing in this evolving landscape. #HealthcareSubscription #HealthcareEconomics #ISPOR
Click here↓↓↓
LifeNextDaily News!
🚀⚡️💰 Revolutionizing healthcare! Learn about GCEA, discount rates, and value-based care at ISPOR 2025. #ISPOR2025 #HealthcareEconomics #ValueBasedCare
Click here↓↓↓
5/9 Nobel-winning economist Paul Krugman describes it as "an arms race between insurance companies trying to game the system to charge more and deliver less and government officials trying to rein them in."
#HealthcareEconomics #SystemFailure
#ABpoli #ABhealth
Maine's new House Bill 2274 could change the game for research funding and amusement operations, sparking heated debates about its financial impact on healthcare and entertainment sectors.
Learn more here!
#ME #TaxReform #MaineLegislation #HealthcareEconomics #ResearchAccountability
Could Nurse Reimbursement Transform Healthcare Economics? 💉💰
#NurseReimbursement #HealthcareEconomics #PatientCare #NursingIndustry #ClinicalLabor #HospitalManagement #HealthcareInnovation #PatientSafety #HealthcareReform #NurseAdvocacy
Screenshot of text that reads: Challenge 2: Disaggregation and sourcing of resource use and unit prices The disaggregation of costs requires a comprehensive mapping of the entire sequencing process. Clinical ES and GS involve multiple stages that may be carried out by different laboratory departments or even outsourced to third parties, as is the case with sequencing. This complicates the identification of appropriate unit costs and resource use items for measurement and valuation. Simply aggregating cost data from various sources might not be reliable if differences in protocols and associated resources utilized between various laboratories are not considered. Accurately measuring costs requires detailed delineation of the sequencing workflow to include all stages, from preanalytic sample collection to postanalytic generation of the test report. This should reflect all steps and work teams involved, accounting for factors such as sample processing volumes, sequencing methods, equipment, and validation procedures, indicating when steps are outsourced and how these were costed (eg, market price or supplier-negotiated prices). This approach better reflects practice across laboratory departments and providers, resulting in a more accurate estimation of costs and resources.
Are #GenomicSequencing costs actually decreasing? #Microcosting studies are vital for understanding the economic cost, but challenges persist in quality, consistency, and comparability of studies bit.ly/4fVHC5t #HealthcareEconomics
Seeing this report, what are your thoughts? Could curing diseases truly become an obstacle for the pharmaceutical industry? Let’s discuss! 🩺🤝 #HealthcareEconomics #FutureOfHealth
Medical Equipment Challenges 🩺
#HealthcarePolicy #Tariffs #GenericDrugs #HealthcareEconomics #Trump #NEWS #economy #healthcare #InsuranceNews
Medical Equipment Challenges 🩺
#HealthcarePolicy #Tariffs #GenericDrugs #HealthcareEconomics #Trump #NEWS #economy #healthcare #InsuranceNews
Generic Drug Costs Could Rise 💊
#HealthcarePolicy #Tariffs #GenericDrugs #HealthcareEconomics #Trump #NEWS #economy #healthcare #InsuranceNews
How Trump’s Tariffs Could Affect your Medication 💊😷💰
#HealthcarePolicy #Tariffs #GenericDrugs #HealthcareEconomics #Trump #NEWS #economy #healthcare #InsuranceNews